Zentalis: Targeting The Achilles' Heel Of Cyclin E1-Positive Platinum-resistant Ovarian Cancer

Ovarian cancer is the second most common gynecologic cancer in the United States. However, its incidence has declined over the past several decades, likely due at least in part to more use of oral contraceptives and less use of menopausal hormone therapy, according to the American Cancer Society.

It is estimated that about 21,010 women will receive a new diagnosis of ovarian cancer and about 12,450 women will die from ovarian cancer this year.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by Prabha Kurup

For comments and feedback: contact editorial@rttnews.com